These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32208795)

  • 1. Pharmacokinetic and pharmacodynamic modeling of levetiracetam: investigation of factors affecting the clinical outcome.
    Karatza E; Markantonis SL; Savvidou A; Verentzioti A; Siatouni A; Alexoudi A; Gatzonis S; Mavrokefalou E; Karalis V
    Xenobiotica; 2020 Sep; 50(9):1090-1100. PubMed ID: 32208795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
    Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
    J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Levetiracetam Seizure Prophylaxis in Severe Traumatic Brain Injury.
    Harlan SS; Philpott CD; Keegan SP; Droege ME; Karve AS; Foreman B; Wakefield D; Mueller EW; Sangha K; Ngwenya LB; Courter JD; Desai P; Droege C
    Ann Pharmacother; 2024 Jul; 58(7):705-714. PubMed ID: 37776163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy.
    Hernández-Mitre MP; Medellín-Garibay SE; Rodríguez-Leyva I; Rodríguez-Pinal CJ; Zarazúa S; Jung-Cook HH; Roberts JA; Romano-Moreno S; Milán-Segovia RDC
    J Pharm Sci; 2020 Jun; 109(6):2070-2078. PubMed ID: 32113977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive Dosage Strategy of Levetiracetam in Chinese Epileptic Patients: Focus on Pregnant Women.
    Duan Y; Yang X; Zhang M; Qi X; Jin Y; Wang Z; Chen L
    J Pharm Sci; 2024 May; 113(5):1385-1394. PubMed ID: 38176454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Performance of Population Pharmacokinetic Models of Levetiracetam in Children and Evaluation of Dosing Regimen.
    Tauzin M; Tréluyer JM; Nabbout R; Chemaly N; Billette de Villemeur T; Desguerre I; Lui G; Gana I; Boujaafar S; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
    J Clin Pharmacol; 2021 Oct; 61(10):1366-1375. PubMed ID: 33997989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Sex, Age, and Weight on Levetiracetam Pharmacokinetics.
    Alzueta N; Ortega A; Aldaz A
    Ther Drug Monit; 2018 Oct; 40(5):628-634. PubMed ID: 29965883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
    Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
    Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy.
    Silva R; Almeida A; Bicker J; Gonçalves J; Carona A; Silva A; Santana I; Sales F; Falcão A; Fortuna A
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33019727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of levetiracetam in neurosurgical ICU patients.
    Ong CLJ; Goh PSJ; Teo MM; Lim TP; Goh KKK; Ang XY; Lim LJK; Jamaludin NHB; Ang BT; Kwa LHA
    J Crit Care; 2021 Aug; 64():255-261. PubMed ID: 34051579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam Pharmacokinetics in a Critically Ill Anephric Patient on Intermittent Hemodialysis.
    Wieruszewski PM; Kashani KB; Rabinstein AA; Frazee E
    Neurocrit Care; 2018 Apr; 28(2):243-246. PubMed ID: 28828726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.
    Wang YH; Wang L; Lu W; Shang DW; Wei MJ; Wu Y
    Acta Pharmacol Sin; 2012 Jun; 33(6):845-51. PubMed ID: 22669118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of levetiracetam in neonates with seizures.
    Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
    J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
    Schoemaker R; Wade JR; Stockis A
    Clin Pharmacokinet; 2018 Jul; 57(7):843-854. PubMed ID: 28884437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy.
    Li Y; Wang ML; Guo Y; Cao YF; Zhao MM; Zhao LM
    Br J Clin Pharmacol; 2023 Mar; 89(3):1152-1161. PubMed ID: 36260320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.